American Century Companies Inc. Purchases 107,448 Shares of Unum Group $UNM

American Century Companies Inc. increased its holdings in shares of Unum Group (NYSE:UNM) by 27.6% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 497,002 shares of the financial services provider’s stock after purchasing an additional 107,448 shares during the period. American Century Companies Inc. owned approximately 0.29% of Unum Group worth $40,138,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. HighTower Advisors LLC boosted its position in shares of Unum Group by 0.3% during the first quarter. HighTower Advisors LLC now owns 60,370 shares of the financial services provider’s stock worth $4,918,000 after buying an additional 201 shares during the period. Connor Clark & Lunn Investment Management Ltd. acquired a new position in Unum Group during the 1st quarter worth approximately $646,000. BTC Capital Management Inc. boosted its position in shares of Unum Group by 5.0% during the 2nd quarter. BTC Capital Management Inc. now owns 71,836 shares of the financial services provider’s stock worth $5,731,000 after acquiring an additional 3,399 shares in the last quarter. Royal Bank of Canada boosted its holdings in Unum Group by 0.5% in the first quarter. Royal Bank of Canada now owns 1,416,124 shares of the financial services provider’s stock valued at $115,358,000 after purchasing an additional 6,648 shares in the last quarter. Finally, Klein Pavlis & Peasley Financial Inc. grew its position in shares of Unum Group by 42.7% in the 2nd quarter. Klein Pavlis & Peasley Financial Inc. now owns 26,681 shares of the financial services provider’s stock valued at $2,155,000 after buying an additional 7,981 shares during the last quarter. 86.57% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research firms have weighed in on UNM. JPMorgan Chase & Co. decreased their price objective on Unum Group from $94.00 to $92.00 and set a “neutral” rating for the company in a research report on Tuesday, November 4th. Evercore ISI boosted their target price on Unum Group from $96.00 to $99.00 and gave the company an “outperform” rating in a report on Wednesday, November 5th. Morgan Stanley upped their price target on Unum Group from $79.00 to $81.00 and gave the stock an “equal weight” rating in a research note on Tuesday, October 7th. Weiss Ratings reissued a “buy (b-)” rating on shares of Unum Group in a research note on Tuesday. Finally, Wells Fargo & Company cut their price objective on shares of Unum Group from $100.00 to $98.00 and set an “overweight” rating for the company in a research report on Wednesday, October 8th. Two equities research analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $94.67.

Insider Activity at Unum Group

In related news, EVP Steven Andrew Zabel sold 7,500 shares of Unum Group stock in a transaction dated Wednesday, November 19th. The shares were sold at an average price of $76.38, for a total value of $572,850.00. Following the sale, the executive vice president directly owned 113,807 shares in the company, valued at $8,692,578.66. This trade represents a 6.18% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Christopher W. Pyne sold 4,000 shares of the stock in a transaction that occurred on Friday, November 7th. The stock was sold at an average price of $78.04, for a total value of $312,160.00. Following the completion of the transaction, the executive vice president directly owned 51,372 shares of the company’s stock, valued at $4,009,070.88. This trade represents a 7.22% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.92% of the stock is currently owned by corporate insiders.

Unum Group Price Performance

NYSE:UNM opened at $75.97 on Friday. Unum Group has a 12-month low of $66.81 and a 12-month high of $84.48. The firm has a market cap of $12.71 billion, a price-to-earnings ratio of 9.09, a price-to-earnings-growth ratio of 1.23 and a beta of 0.37. The company’s 50-day moving average is $76.47 and its two-hundred day moving average is $76.60. The company has a current ratio of 0.30, a quick ratio of 0.30 and a debt-to-equity ratio of 0.31.

Unum Group (NYSE:UNM) last posted its quarterly earnings data on Monday, November 3rd. The financial services provider reported $2.09 EPS for the quarter, missing analysts’ consensus estimates of $2.15 by ($0.06). The company had revenue of $3.25 billion for the quarter, compared to analyst estimates of $3.31 billion. Unum Group had a net margin of 11.77% and a return on equity of 13.44%. The company’s revenue was up 5.0% compared to the same quarter last year. During the same period in the prior year, the company earned $2.13 EPS. Unum Group has set its FY 2025 guidance at EPS. Research analysts expect that Unum Group will post 9.14 EPS for the current year.

Unum Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, November 14th. Stockholders of record on Friday, October 24th were issued a $0.46 dividend. The ex-dividend date of this dividend was Friday, October 24th. This represents a $1.84 annualized dividend and a dividend yield of 2.4%. Unum Group’s payout ratio is 35.87%.

Unum Group Profile

Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block segment. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.